Pulmonary hypertension therapy and COPD: still many questions to be answered

Eur Respir J. 2009 Feb;33(2):450-2; author reply 452-3. doi: 10.1183/09031936.00161808.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antihypertensive Agents / pharmacology
  • Bosentan
  • Humans
  • Hypertension, Pulmonary / complications*
  • Hypertension, Pulmonary / drug therapy*
  • Lung / drug effects
  • Pulmonary Artery / pathology
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Pulmonary Disease, Chronic Obstructive / pathology
  • Research Design
  • Sulfonamides / pharmacology
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Sulfonamides
  • Bosentan